DE2923955A1 - Pharmazeutisches mittel zur behandlung sexueller frigiditaet und impotenz - Google Patents

Pharmazeutisches mittel zur behandlung sexueller frigiditaet und impotenz

Info

Publication number
DE2923955A1
DE2923955A1 DE19792923955 DE2923955A DE2923955A1 DE 2923955 A1 DE2923955 A1 DE 2923955A1 DE 19792923955 DE19792923955 DE 19792923955 DE 2923955 A DE2923955 A DE 2923955A DE 2923955 A1 DE2923955 A1 DE 2923955A1
Authority
DE
Germany
Prior art keywords
impotence
frigidity
pharmaceutical agent
rats
sexual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19792923955
Other languages
German (de)
English (en)
Inventor
Gian Luigi Prof Gessa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tecnofarmaci SpA
Original Assignee
Tecnofarmaci SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnofarmaci SpA filed Critical Tecnofarmaci SpA
Publication of DE2923955A1 publication Critical patent/DE2923955A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19792923955 1978-06-14 1979-06-13 Pharmazeutisches mittel zur behandlung sexueller frigiditaet und impotenz Pending DE2923955A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24578/78A IT1096665B (it) 1978-06-14 1978-06-14 Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza

Publications (1)

Publication Number Publication Date
DE2923955A1 true DE2923955A1 (de) 1980-01-24

Family

ID=11214033

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19792923955 Pending DE2923955A1 (de) 1978-06-14 1979-06-13 Pharmazeutisches mittel zur behandlung sexueller frigiditaet und impotenz

Country Status (5)

Country Link
BE (1) BE876968A (xx)
DE (1) DE2923955A1 (xx)
FR (1) FR2428439A1 (xx)
IT (1) IT1096665B (xx)
ZA (1) ZA792923B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000970A1 (en) * 1983-08-26 1985-03-14 Balkanyi Ivan Pharmaceutical compositions having appetite reducing activity and a process for their preparation

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1269826B (it) * 1994-05-24 1997-04-15 Paolo Minoia Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate
DK2368553T3 (en) 2003-04-08 2015-02-09 Progenics Pharm Inc Pharmaceutical preparation comprising methylnaltrexone
EP2134718A2 (en) 2007-03-29 2009-12-23 Progenics Pharmaceuticals, Inc. Crystal forms of (r)-n-methylnaltrexone bromide and uses thereof
PL2137191T3 (pl) 2007-03-29 2016-12-30 Antagoniści obwodowego receptora opioidowego i ich zastosowania
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000970A1 (en) * 1983-08-26 1985-03-14 Balkanyi Ivan Pharmaceutical compositions having appetite reducing activity and a process for their preparation

Also Published As

Publication number Publication date
ZA792923B (en) 1980-07-30
BE876968A (fr) 1979-10-01
IT7824578A0 (it) 1978-06-14
FR2428439A1 (fr) 1980-01-11
IT1096665B (it) 1985-08-26

Similar Documents

Publication Publication Date Title
DE60009346T2 (de) Buprenorphin enthaltende analgetische zusammensetzungen
DE69933874T2 (de) Topische zusammensetzung enthaltend ein opioid-analgetika und einen nmda-antagonist
DE4037708A1 (de) Appetitzuegler und verfahren zu seiner anwendung
DE60213648T2 (de) Verwendung von thymulinähnlichen peptiden zur herstellung von schmerzmitteln
WO2001013903A2 (de) Behandlung des restless leg syndroms mit einer kombination von clonidin und opioid
DE10197266T5 (de) Verfahren zur örtlichen Betäubung und Schmerzstillung
EP0200155B1 (de) Wässrige Chloritmatrix-Lösung
DE69027220T2 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
DE202006018609U1 (de) Verwendung von Opioidformulierungen in nadellosen Vorrichtungen zur Medikamentenverabreichung
DE19938825A1 (de) Wirkstoffkombination mit Clonidin
EP0185210A2 (de) Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten
DE3687575T2 (de) Verwendung von 6-methylen-6-desoxy-n-cyclopropylmethyl-14-hydroxydihydronormorphin.
EP0639077A1 (de) Arzneimittel zur erhöhung des testosteronspiegels.
DE2923955A1 (de) Pharmazeutisches mittel zur behandlung sexueller frigiditaet und impotenz
DE69328792T2 (de) Behandlung von migräne
EP0083925B1 (de) Verfahren zur Behandlung der Azyklie bei Schafen oder Rindern
DE69030584T2 (de) Verfahren sowie zusammensetzungen zur behandlung mit vitaminmineral
DE3445183A1 (de) Proglumide enthaltende arzneimittel mit analgetischer wirkung
Fekete et al. Comparative effects of the ACTH 4–9 analogue (ORG 2766), ACTH 4–10 and [d-Phe7] ACTH 4ndash; 10 on medial septal self-stimulation behaviour in rats
DE69918165T2 (de) Doramectinformulierungen
DE10163421A1 (de) Verwendung von (+)-(1S,2S)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)phenol als Antiemetikum
DE60024408T2 (de) Verwendung von trizyklischen antidepressiva zur behandlung von kopfschmerzen
DE69118685T3 (de) Zusammensetzungen für euthanasie
Beleslin et al. Differences in central effects of β-endorphin and enkephalins: β-endorphin a potent psychomotor stimulant
DE2117762A1 (de) Behandlung von Alopecia und pharmazeutische Präparation für die Durchführung der Behandlung

Legal Events

Date Code Title Description
OAP Request for examination filed
OD Request for examination
OHW Rejection